Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2008
11/27/2008CA2683288A1 Crystalline and amorphous forms of peptide
11/27/2008CA2681480A1 Memory and learning impairments associated with disruption of ephrin receptor a6 (epha6) gene
11/26/2008EP1995321A2 Gene disruptions, compositions and methods relating thereto
11/26/2008EP1995318A1 Mammalian cell surface antigens; related reagents
11/26/2008EP1995317A1 Mammalian cell surface antigens; related reagents
11/26/2008EP1995315A2 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
11/26/2008EP1995309A1 Recombinant protein production in avian EBx® cells
11/26/2008EP1995256A1 EPHA2 T-cell epitope agonists and uses therefor
11/26/2008EP1994942A1 Pharmaceutical compositions comprising telomerase, and uses thereof
11/26/2008EP1994941A2 Medicine containing at least one oxidised protein
11/26/2008EP1994940A1 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects
11/26/2008EP1994939A1 Pharmaceutical composition containing ghrp-6 capable of preventing and eliminating fibrosis and other forms of pathological deposit in tissue
11/26/2008EP1994938A1 New lipoglycodepsipeptide compositions
11/26/2008EP1994937A2 Prevention and treatment of amyloidogenic disease
11/26/2008EP1994157A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
11/26/2008EP1994155A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling
11/26/2008EP1994153A2 Chimeric kunitz domains and their use
11/26/2008EP1994152A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/26/2008EP1994146A1 Cancerous disease modifying antibody 141205-02
11/26/2008EP1994081A1 Novel poly(ethylene oxide)-block-poly(ester) block copolymers
11/26/2008EP1994053A1 Soluble gp130 molecule variants useful as a medicament
11/26/2008EP1994048A2 Pegylated mutated clostridium botulinum toxin
11/26/2008EP1993673A2 Injectable combination therapy for eye disorders
11/26/2008EP1993672A2 Na/k-atpase ligand
11/26/2008EP1993657A2 Method and system for delivery of neurotoxins
11/26/2008EP1993594A1 Use of caspases for the preparation of medicaments
11/26/2008EP1993593A1 Pharmaceutical compositions comprising sods and prolamine based peptide fragments
11/26/2008EP1993592A2 Compositions containing lactoferrin, and methods of using same to promote growth of skin cells
11/26/2008EP1993591A2 Targeted delivery of pharmaceutical compounds
11/26/2008EP1993590A2 Compostions and methods for administering gdnf ligand family proteins
11/26/2008EP1993589A2 Treatments for neurological disorders
11/26/2008EP1993587A2 Use of the engrailed homeodomain protein as an anxiolytic
11/26/2008EP1993586A2 Method for treating peripheral arterial disease with zinc finger proteins
11/26/2008EP1993585A2 Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases
11/26/2008EP1993583A2 Inhibitors of membrane type-1 matrix metalloproteinase for the treatment of insulin-dependent diabetes mellitus
11/26/2008EP1993582A2 Proteins containing a fluorinated amino acid, and methods of using same
11/26/2008EP1993581A1 Novel use of ubiquitin c-terminal hydrolase-l1
11/26/2008EP1993515A2 Method for solubilizing, dispersing, and stabilizing materials, products manufactured according to said method, and use thereof
11/26/2008EP1993383A2 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation
11/26/2008EP1993357A2 Formulations for a tight junction effector
11/26/2008EP1809662B1 Deamidated interferon-beta
11/26/2008EP1800134B1 Method for diagnosing and treating crohn's disease
11/26/2008EP1689349A4 A method of inducing melanogenesis in humans with mc1r variant alleles
11/26/2008EP1673388B1 Cxcl8 antagonists
11/26/2008EP1594492B1 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/26/2008EP1521770B1 Method for the production of protamine
11/26/2008EP1515752B1 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
11/26/2008EP1434592B1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
11/26/2008EP1419173B1 Peptides that bind to atherosclerotic lesions
11/26/2008EP1396539B1 Human-type anti-blood coagulation factor viii antibody
11/26/2008EP1381382B1 Methods and compositions for the treatment of diseases of the eye
11/26/2008EP1370572B1 Mitochondrial membrane permeabilization by hiv-1 vpr and methods of screening
11/26/2008EP1328267B1 Method of treating cancer using dithiocarbamate derivatives
11/26/2008EP1276492B1 P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
11/26/2008EP1257642B1 Partners of ptb1 domain of fe65, preparation and uses
11/26/2008EP1173481B1 Inactivated cytokines for immunisation
11/26/2008EP1153609B1 Amino acid-containing albumin preparations
11/26/2008EP1124953B1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
11/26/2008EP1108042B1 Molecules designated b7l-1
11/26/2008EP0969875B1 Naked dna-mediated gene transfer into medullary motor neurons
11/26/2008EP0957943B2 Matrix-free osteogenic devices, implants and methods of use thereof
11/26/2008EP0865293B1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
11/26/2008EP0821732B1 Altered polypeptides with increased half-life
11/26/2008EP0735893B1 Pan dr-binding peptides for enhancement of the immune response
11/26/2008CN101313068A Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
11/26/2008CN101313066A Modulation of glucocorticoid receptor expression
11/26/2008CN101313063A Cancer-rejection antigen peptide derived from glypican-3 (GPC3) for use in HLA-A2-positive patient and pharmaceutical comprising the antigen
11/26/2008CN101312987A Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia
11/26/2008CN101312986A Method of producing a modified (poly)peptide
11/26/2008CN101312745A Therapeutic agent for skin or skin repair-promoting agent comprising ghrelin, derivative thereof or substance capable of acting on ghs-r1a as active ingredient
11/26/2008CN101312740A Wwox gene, vectors containing the same, and uses in treatment of cancer
11/26/2008CN101312739A Therapeutic agent for skin or skin repair-promoting agent comprising des-acylghrelin or derivative thereof as active ingredient
11/26/2008CN101312660A High-potency sweetener for weight management and compositions sweetened therewith
11/26/2008CN101311193A Complexes using recombined triple helix support as base
11/26/2008CN101311192A Process for high-efficiency expressing sTNFR/Fc fusion protein in yeast and uses thereof
11/26/2008CN101311188A Small molecule peptides inhibitor of human heparinase
11/26/2008CN101310779A Device and medicinal preparation containing neuroregulation protein
11/26/2008CN101310770A Antibodies against cancer
11/26/2008CN101310768A Medicine composition for treating hepatic disease and use thereof
11/26/2008CN101310767A Cryosurgery anticancer antigen preparation and preparation method thereof
11/26/2008CN101310766A New use of neuroregulation protein
11/26/2008CN101310765A Safe dose of neuroregulation protein applied to human
11/26/2008CN100436595C Method for diagnosis and treatment of hair eipidermal tumor using human's CYLD gene and its coded products
11/26/2008CN100436588C Blood sugar reducing method of orally taking human insulin-like growth factor-I produced in silkworm bioreactor
11/26/2008CN100436578C Modulation of the transcription of pro-inflammatory gene products
11/26/2008CN100436482C Long effective amalgamation protein of erythropoietin of human, preparing and purifying methods
11/26/2008CN100436481C Targeted anti-tumour fused protein containing adenovirus E40rf4 protein
11/26/2008CN100436480C Platelet glycoprotein IB-alpha variant fusion polypeptides and methods of use thereof
11/26/2008CN100436471C Polynucleotide for identifying polypeptide OT3 and coding OT3 of tumor cell and uses thereof
11/26/2008CN100436470C Polynucleotide for identifying polypeptide OT10 and coding OT10 of tumor cell and uses thereof
11/26/2008CN100435879C Electro-powder
11/26/2008CN100435859C Methods and compositions for healing and repair of articular cartilage
11/26/2008CN100435849C Anti-tumor agent using interleukin-23 gene
11/26/2008CN100435848C Gene treatment to raise feed efficiency and promote growth of farm animal
11/26/2008CN100435843C Compsns. of thymopentin and interferon
11/26/2008CN100435806C Anionic polymers as toxin binders and antibacterial agents
11/26/2008CN100435788C Inhibitor for perioperative blood sugar elevation
11/26/2008CN100435784C Method for preparing inorganic salt nanometer particles containing and packing traditional Chinese medicine and its application
11/26/2008CN100435775C Use of 3-position cyclosporin derivatives for hair growth
11/25/2008US7456272 Neurotoxins with enhanced target specificity
1 ... 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 ... 3163